Antiproliferative activity of olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F05%3A00002165" target="_blank" >RIV/61989592:15310/05:00002165 - isvavai.cz</a>
Alternative codes found
RIV/00209805:_____/05:#0000023 RIV/61389030:_____/05:00343928
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Antiproliferative activity of olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor.
Original language description
The study describes the protein kinase selectivity profile, as well as the binding mode of olomoucine II in the catalytic cleft of CDK2, as determined from cocrystal analysis. Apart from the main cell cycle-regulating kinase CDK2, olomoucine II exerts specificity for CDK7 and CDK9, with important functions in the regulation of RNA transcription. In vitro anticancer activity of the inhibitor in a panel of tumor cell lines shows a wide potency range with a slight preference for cells harboring a wild-typep53 gene. Cell-based assays confirmed activation of p53 protein levels and events leading to accumulation of p21(WAF1). Additionally, in olomoucine II-treated cells, Mdm2 was found to form a complex with the ribosomal protein L11, which inhibits Mdm2 ubiquitin ligase function. We conclude that perturbations in RNA synthesis may lead to activation of p53 and that this contributes to the antiproliferative potency of cyclindependent kinase inhibitors.
Czech name
aktivita olomoucinu, nového inhibitoru cyklin-dependentních kinas
Czech description
Práce popisuje inhibiční profil olomoucinu II a na základě rentgenostrukturní analýzy také orientaci molekuly v aktivním místě CDK2. Olomoucin II vykazuje výraznou selektivitu k CDK7 a CDK9, které mají důležité funkce při regulaci transkripce RNA. Buněčné působení inhibitoru je provázeno aktivací nádorového supresoru p53 a jím řízeného genu p21WAF1. Navíc dochází v buňkách k destrukci jadérek, provázených uvolněním proteinu L11 a jeho vazbu na Hdm2, což může přispívat ke stabilizaci p53.
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EF - Botany
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2005
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Cellular and Molecular Life Sciences
ISSN
1420-682X
e-ISSN
—
Volume of the periodical
62
Issue of the periodical within the volume
15
Country of publishing house
CH - SWITZERLAND
Number of pages
31
Pages from-to
1763-71
UT code for WoS article
—
EID of the result in the Scopus database
—